Literature DB >> 8094267

Linkage analysis of schizophrenia with five dopamine receptor genes in nine pedigrees.

H Coon1, W Byerley, J Holik, M Hoff, M Myles-Worsley, L Lannfelt, P Sokoloff, J C Schwartz, M Waldo, R Freedman.   

Abstract

Alterations in dopamine neurotransmission have been strongly implicated in the pathogenesis of schizophrenia for nearly 2 decades. Recently, the genes for five dopamine receptors have been cloned and characterized, and genetic and physical map information has become available. Using these five loci as candidate genes, we have tested for genetic linkage to schizophrenia in nine multigenerational families which include multiple affected individuals. In addition to testing conservative disease models, we have used a neurophysiological indicator variable, the P50 auditory evoked response. Deficits in gating of the P50 response have been shown to segregate with schizophrenia in this sample and may identify carriers of gene(s) predisposing for schizophrenia. Linkage results were consistently negative, indicating that a defect at any of the actual receptor sites is unlikely to be a major contributor to schizophrenia in the nine families studied.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094267      PMCID: PMC1682188     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  38 in total

1.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

Authors:  I Creese; D R Burt; S H Snyder
Journal:  Science       Date:  1976-04-30       Impact factor: 47.728

2.  Polymorphic DNA region adjacent to the 5' end of the human insulin gene.

Authors:  G I Bell; J H Karam; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

3.  Thought disorder in schizophrenia: cognitive and neuroscience approaches.

Authors:  T Patterson; H E Spohn; D P Bogia; K Hayes
Journal:  Schizophr Bull       Date:  1986       Impact factor: 9.306

4.  Bimodal distribution of dopamine receptor densities in brains of schizophrenics.

Authors:  P Seeman; C Ulpian; C Bergeron; P Riederer; K Jellinger; E Gabriel; G P Reynolds; W W Tourtellotte
Journal:  Science       Date:  1984-08-17       Impact factor: 47.728

5.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

6.  A diagnostic interview: the schedule for affective disorders and schizophrenia.

Authors:  J Endicott; R L Spitzer
Journal:  Arch Gen Psychiatry       Date:  1978-07

7.  Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses.

Authors:  C Siegel; M Waldo; G Mizner; L E Adler; R Freedman
Journal:  Arch Gen Psychiatry       Date:  1984-06

8.  3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors.

Authors:  A J Cross; T J Crow; F Owen
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

9.  Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients.

Authors:  R Freedman; L E Adler; M C Waldo; E Pachtman; R D Franks
Journal:  Biol Psychiatry       Date:  1983-05       Impact factor: 13.382

10.  Report of the second chromosome 11 workshop.

Authors:  C Junien; V van Heyningen; G Evans; P Little; M Mannens
Journal:  Genomics       Date:  1992-03       Impact factor: 5.736

View more
  9 in total

Review 1.  Molecular genetics of schizophrenia: a critical review.

Authors:  Neeraj Berry; Vaidehi Jobanputra; Hemraj Pal
Journal:  J Psychiatry Neurosci       Date:  2003-11       Impact factor: 6.186

2.  A search for association between schizophrenia and dopamine-related alleles.

Authors:  E Jönsson; S Brené; T Geijer; L Terenius; A Tylec; M L Persson; G Sedvall
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

Review 3.  The role of candidate genes in the etiology of schizophrenia.

Authors:  K C Murphy; P McGuffin
Journal:  Mol Med       Date:  1996-11       Impact factor: 6.354

4.  Mitochondrial involvement in schizophrenia and other functional psychoses.

Authors:  S A Whatley; D Curti; R M Marchbanks
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

5.  Molecular genetics of psychopathologies: a search for simple answers to complex problems.

Authors:  B E Ginsburg; T M Werick; J I Escobar; S Kugelmass; J J Treanor; L Wendtland
Journal:  Behav Genet       Date:  1996-05       Impact factor: 2.805

6.  Amphiphysin I but not dynamin I nor synaptojanin mRNA expression increased after repeated methamphetamine administration in the rat cerebrum and cerebellum.

Authors:  Mitsuko Hamamura; Jiro Okouchi; Hidetoshi Ozawa; Yoshihiko Kimuro; Akiko Iwaki; Yasuyuki Fukumaki
Journal:  J Neural Transm (Vienna)       Date:  2012-12-08       Impact factor: 3.575

7.  Id2 is required for specification of dopaminergic neurons during adult olfactory neurogenesis.

Authors:  Matthew C Havrda; Brent T Harris; Akio Mantani; Nora M Ward; Brenton R Paolella; Verginia C Cuzon; Hermes H Yeh; Mark A Israel
Journal:  J Neurosci       Date:  2008-12-24       Impact factor: 6.167

Review 8.  Dopamine partial agonists: a new class of antipsychotic.

Authors:  Jeffrey A Lieberman
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 9.  Translational utility of rodent hippocampal auditory gating in schizophrenia research: a review and evaluation.

Authors:  J Smucny; K E Stevens; A Olincy; J R Tregellas
Journal:  Transl Psychiatry       Date:  2015-06-23       Impact factor: 6.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.